Vagus Nerve Stimulation for Breast Cancer and Lymphoma
Neuromodulation of Cardiovascular Risks Associated With Cardiotoxic Chemotherapy
- Age
- 18 – 99
- Sex
- Any
- Trial phase
- Early Phase 1
- Study type
- Interventional
- Purpose
- Device Feasibility
- Participants needed
- 104 (estimated)
- Sponsor
- University of Oklahoma · Other
This trial is looking for patients with breast cancer or lymphoma who have recently received certain chemotherapy. Participants will use a device to stimulate a nerve in the neck to see if it helps improve heart health and inflammation levels.
You may be able to join if
- I am over 18 years old.
- I have received anthracycline-based chemotherapy in the last 30 days.
- I have had chest radiation.
- I am over 50 years old.
- I have type 2 diabetes.
- I have hypertension.
- I currently smoke.
- I have a body mass index of 30 or more.
You may not be able to join if
- I have an atrial paced rhythm.
- I have a history of seizures and am currently being treated.
- I have a history of vasovagal syncope.
- I have end stage liver disease.
- I have end stage kidney disease.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your EligibilityThis study is to determine if low level vagus nerve stimulation will lead to improvement in heart function, heart rate variation, and in the levels of certain chemical markers of inflammation in study participants' blood.
Loading trial locations…